$CSTE

CSTE (Nasdaq) Form 144: insiders list RSU‑linked sales, examples shown

Caesarstone Ltd. (CSTE) has filed a Form 144, indicating proposed sales of Ordinary Shares linked to previously granted Restricted Share Units (RSUs) by an affiliate. The filing specifies various grant dates and associated share counts, with Oppenheimer & Co Inc. listed as the broker. This suggests upcoming dispositions of shares by insiders rather than new issuances by the company.

Original reporting
Published May 21, 2026, 4:39 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 21, 2026, 5:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CSTE
Neutral
medium confidence
Mentioned
$CSTE
Relevance
6/10
AlphAI data visualization · based on Stock Titan
Decision brief

The 30-second read

$CSTENeutralLow
01

Why it matters

While insider sales can sometimes signal caution, in this context, they are likely routine and do not imply adverse company fundamentals.

02

Market read

The event is specific to Caesarstone Ltd. and has limited immediate impact on the broader market or industry sectors.

03

What to watch

The company's fundamentals, upcoming earnings, or other news could offset the impact of insider sales; consider broader market conditions and technical indicators.

Relevance 6/10Timing: short-term (within days to weeks)

Background

Caesarstone Ltd. filed a Form 144 indicating planned insider sales linked to RSUs, which is a routine disclosure for insiders intending to sell shares.

Company-level read

Ticker impact

$CSTENeutralMedium confidence
Context

The filing indicates insider sales linked to RSUs, suggesting potential insider profit-taking rather than company performance issues.

Expected impact

Potential slight decline in share price in the short term, approximately 2-4%, contingent on market reaction.

Evidence & confidence

The filing indicates planned insider sales, which are common and do not necessarily reflect company fundamentals. Market interpretation can vary, and other factors may influence price movement.

Market effects

The filing's impact is likely limited to the specific company; minimal sector-wide implications unless similar filings are observed across the industry.

Negligible; the event is company-specific and does not suggest regional economic shifts.

Negligible; the event is localized to Caesarstone Ltd. and does not influence global markets.

Counterpoint

Insider sales may be a sign of insiders diversifying holdings or personal liquidity needs, not necessarily a negative outlook on the company's prospects.

Key entities

  • Caesarstone Ltd.

    A manufacturer of quartz surfaces for the construction and interior design industries.

  • Oppenheimer & Co Inc.

    The broker facilitating the insider sales of CSTE shares.

Related articles

$CSTEMed

Caesarstone Q2 Earnings Call Highlights

Caesarstone (NASDAQ:CSTE) reported Q2 operating expenses of $33.4M (34.6% of revenue). U.S. revenue fell 14.1% to about $42.7M, while Australia rose to $20.3M (up 10.1% constant-currency) and Israel revenue rose 32.4% constant-currency. Net cash was $51.8M. The company cited U.S. tariff changes and ongoing silica-related legal claims.

$CSTEMed

Caesarstone Ltd. (CSTE): Financial results for Q2 2026

Caesarstone Ltd. (CSTE) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Caesarstone Reports Second Quarter 2026 Financial Results - Revenue of $96.6 Million and Gross Margin of 24.0% - - Recently Announced U.S. Quartz Tariff-Rate Quota on Imports, Effective August 15, 2026 - - Evaluating the Impact of New U.S. Tariffs on the Timing of Po

$LDOSMed

Leidos expands production capacity to build thousands of cruise missiles for U.S. strike arsenal

Leidos is expanding production capacity to build thousands of cruise missiles for the U.S. under a framework agreement with the Department of War. The company plans to deliver the first weapons in 2027, with full-rate production starting in 2028. Leidos is investing in facilities, supply chain, and workforce to scale production quickly, with work concentrated in Alabama and Tennessee.